Tag: Martin Shkreli
Protesters shut down Milo Yiannopoulos event at UC Davis
A speech by right-wing commentator Milo Yiannopoulos’ at UC Davis was over before it even started Friday after protests erupted, forcing sponsors to cancel the event.
HRC, Treatment Action Group, and the Fair Pricing Coalition Launch #FairDrugPricesNow Campaign
Yesterday, the Human Rights Campaign (HRC) Foundation, the educational arm of America’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ) civil rights organisation, joined with the Treatment Action Group (TAG) and the Fair Pricing Coalition (FPC) in launching #FairDrugPricesNow, a public education and outreach campaign to mobilise LGBTQ people and their allies to address the alarming rise of prescription drug prices in the United States.
After Turing Pharmaceuticals’ Outrageous Price Hike on Life-Saving Drug, Low-Cost Alternative Emerge
Express Scripts and Imprimis Pharmaceuticals announce partnership for low-cost alternative in response to unconscionable decision from Martin Shkreli’s Turing Pharmaceuticals to continue price hike on Daraprim.
HRC Slams Ridiculous Announcement that Turing Pharmaceuticals will “Roll Back” Price on Daraprim
Making no commitments, Shkreli says life-saving treatment will still cost at least $375, more than 2,500 percent higher than the original Daraprim price.
New York Attorney General Answers HRC’s Call, Launches Inquiry Into Turing Pharmaceuticals
Today, at the urging of the Human Rights Campaign (HRC), the New York attorney general has begun investigating whether Turing Pharmaceuticals, which recently imposed an unconscionable 5000 percent price hike on the life-saving drug Daraprim, may have violated antitrust laws by limiting its distribution. Chad Griffin, President of HRC, America’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organisation, released the following statement:
The Clock Is Ticking: 14 Days Since Turing CEO Promised to Roll Back Price Hike
HRC calls on Turing Chief Martin Shkreli to fulfil his pledge.